Cardinal Health 8-K Signals Financial Update, Regulation FD Disclosure
Ticker: CAH · Form: 8-K · Filed: Jan 9, 2024 · CIK: 721371
| Field | Detail |
|---|---|
| Company | Cardinal Health INC (CAH) |
| Form Type | 8-K |
| Filed Date | Jan 9, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: financial-condition, regulation-fd, corporate-update
TL;DR
**Cardinal Health just dropped an 8-K about financial results and Regulation FD, so expect news.**
AI Summary
Cardinal Health, Inc. filed an 8-K on January 9, 2024, to report on 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure.' This filing indicates that the company is likely providing an update on its financial performance or making a disclosure of material non-public information. For investors, this matters because it signals that important financial news, potentially impacting the stock price (CAH), is either being released or has just been released, requiring close attention to the details of the associated announcement.
Why It Matters
This filing indicates that Cardinal Health is providing an update on its financial performance or making a material disclosure, which could directly influence investor perception and the stock's valuation.
Risk Assessment
Risk Level: medium — The filing itself is administrative, but the underlying financial disclosures it points to could carry significant risk or opportunity for investors.
Analyst Insight
A smart investor would immediately look for the accompanying press release or investor presentation that details the 'Results of Operations and Financial Condition' and the specifics of the 'Regulation FD Disclosure' to understand the financial implications for Cardinal Health (CAH).
Key Players & Entities
- Cardinal Health, Inc. (company) — the registrant filing the 8-K
- Ohio (location) — state of incorporation for Cardinal Health, Inc.
- January 9, 2024 (date) — date of earliest event reported and filing date
- CAH (company) — trading symbol for Cardinal Health, Inc. on the New York Stock Exchange
- New York Stock Exchange (company) — exchange where Cardinal Health, Inc. common shares are registered
FAQ
What specific items are being reported in this 8-K filing by Cardinal Health, Inc.?
Cardinal Health, Inc. is reporting on 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure' as per the ITEM INFORMATION section of the filing.
What is the filing date and the date of the earliest event reported for this 8-K?
Both the filing date and the date of the earliest event reported are January 9, 2024, as stated in the filing.
What is the trading symbol and the exchange where Cardinal Health, Inc. common shares are registered?
The trading symbol for Cardinal Health, Inc. is CAH, and its common shares are registered on the New York Stock Exchange.
What is Cardinal Health, Inc.'s state of incorporation and IRS Employer Identification Number?
Cardinal Health, Inc. is incorporated in Ohio, and its IRS Employer Identification Number is 31-0958666.
What is the business address and phone number of Cardinal Health, Inc. as listed in the filing?
The business address is 7000 Cardinal Place, Dublin, Ohio 43017, and the telephone number is (614) 757-5000.
Filing Stats: 527 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2024-01-09 06:48:04
Filing Documents
- cah-20240109.htm (8-K) — 29KB
- exhibit991-january92024pre.htm (EX-99.1) — 45KB
- image_0a.jpg (GRAPHIC) — 9KB
- 0000721371-24-000005.txt ( ) — 220KB
- cah-20240109.xsd (EX-101.SCH) — 2KB
- cah-20240109_lab.xml (EX-101.LAB) — 24KB
- cah-20240109_pre.xml (EX-101.PRE) — 12KB
- cah-20240109_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On January 9, 2024, Cardinal Health, Inc. (the "Company") issued a news release announcing, among other things, progress on the Company's ongoing business and portfolio review, including an updated enterprise operating and segment reporting structure, and an update to its fiscal year 2024 non-GAAP diluted earnings per share outlook. In the news release, the Company also provided an update to its previous expectations for Medical segment profit for the quarter ended December 31, 2023. A copy of this news release is included as Exhibit 99.1 to this report.
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. The Company today will host a conference call beginning at 8:30 a.m. Eastern time during which management will discuss today's announcements. The event will be live-webcast and archived on the Company's Investor Relations website. To access the webcast and corresponding slide presentation, visit ir.cardinalhealth.com. No access code is required.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits . 99.1 News release issued by the Company on January 9, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Cardinal Health, Inc. (Registrant) Date: January 9, 2024 By: /s/ Aaron E. Alt Name: Aaron E. Alt Title: Chief Financial Officer 3